NAD<sup>+</sup> analog reveals PARP-1 substrate-blocking mechanism and allosteric communication from catalytic center to DNA-binding domains.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29487285.
- Also identified by DOI 10.1038/s41467-018-03234-8 and PMC identifier 5829251.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
PARP-1 cleaves NAD<sup>+</sup> and transfers the resulting ADP-ribose moiety onto target proteins and onto subsequent polymers of ADP-ribose. An allosteric network connects PARP-1 multi-domain detection of DNA damage to catalytic domain structural changes that relieve catalytic autoinhibition; however, the mechanism of autoinhibition is undefined. Here, we show using the non-hydrolyzable NAD<sup>+</sup> analog benzamide adenine dinucleotide (BAD) that PARP-1 autoinhibition results from a selective block on NAD<sup>+</sup> binding. Following DNA damage detection, BAD binding to the catalytic domain leads to changes in PARP-1 dynamics at distant DNA-binding surfaces, resulting in increased affinity for DNA damage, and providing direct evidence of reverse allostery. Our findings reveal a two-step mechanism to activate and to then stabilize PARP-1 on a DNA break, indicate that PARP-1 allostery influences persistence on DNA damage, and have important implications for PARP inhibitors that engage the NAD<sup>+</sup> binding site.
Medical subject headings
- NAD
- Poly (ADP-Ribose) Polymerase-1